Emerging Strategies and Advances in Treatment of Solid Tumors and Hematological Malignancies for Practicing Physicians and Healthcare Professionals 2012

Emerging Strategies and Advances in Treatment of Solid Tumors and Hematological Malignancies for Practicing Physicians and Healthcare Professionals 2012 is a conference that covers topics such as:

• Optimal use of EGFR TKI’s, VEGF TKIs and EML4/ALK targeted agents based on biomarkers for lung cancer
• Histology in patient selection for integration of targeted therapy for lung cancer
• VEGF and EGFR based combination therapy for colorectal cancer
• Treating breast cancer patients with integration of novel cytotoxic agents including antibody-drug conjugates
• Novel treatment options for pancreatic neuroendocrine tumors and pancreatic cancer
• Multidisciplinary approaches in the management of rectal cancer
• Emerging treatment options for renal cell carcinoma
• New therapeutic options for prostate cancer
• Novel therapies for lymphomas
• New therapeutic options in the management of malignant melanoma
• Updates in the treatment of leukemia
• Novel approaches in the treatment of relapsed multiple myeloma
• Practice guidelines and their impact on reimbursement issues in cancer treatment
• Supportive cancer care in the era of targeted therapy

Emerging Strategies and Advances in Treatment of Solid Tumors and Hematological Malignancies for Practicing Physicians and Healthcare Professionals 2012 brings together radiation oncologists, oncologists/hematologists, researchers, surgical oncologists, registered nurses, registered pharmacists, physician assistants, urologists and nurse practitioners.